A safety and feasibility Study

Autologous bone marrow-derived ex vivo expanded mesenchymal stem cell tranplantation in patients with an acute myocardial infarction treated by successful primary percutaneous transluminal coronary angioplasty: a safety and feasibility study

Aim of the study

To assess the safety and efficacy of intramyocardial injection of autologous ex-vivo expanded mesenchymal stem cells after successful primaryt percutaneous transluminal coronary angioplasty